Tag: next generation mRNA-based vaccines
GSK, CureVac team up to develop and manufacture vaccine against COVID-19 mutants
UK-based GlaxoSmithKline announced today that it has partnered with German pharmaceutical company CureVac to jointly develop next-generation mRNA vaccines for emerging COVID-19 variants.
The €150m...
Featured Article
Why energy is becoming a strategic asset for manufacturers
Energy is no longer just a cost centre for manufacturers – it is fast becoming a strategic lever for efficiency, resilience and growth.
